Department of Pharmacology, School of Basic Medical Science, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Department of Pharmacology, School of Basic Medical Science, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Exp Neurol. 2024 Oct;380:114892. doi: 10.1016/j.expneurol.2024.114892. Epub 2024 Jul 22.
T-cell death-associated gene 8 (TDAG8), a G-protein-coupled receptor sensing physiological or weak acids, regulates inflammatory responses. However, its role in traumatic brain injury (TBI) remains unknown. Our recent study showed that delayed CO postconditioning (DCPC) has neuroreparative effects after TBI. We hypothesized that activating astrocytic TDAG8 is a key mechanism for DCPC. WT and TDAG8 mice received DCPC daily by transiently inhaling 10% CO after controlled cortical impact (CCI). HBAAV2/9-GFAP-m-TDAG8-3xflag-EGFP was used to overexpress TDAG8 in astrocytes. The beam walking test, mNSS, immunofluorescence and Golgi-Cox staining were used to evaluate motor function, glial activation and dendritic plasticity. DCPC significantly improved motor function; increased total dendritic length, neuronal complexity and spine density; inhibited overactivation of astrocytes and microglia; and promoted the expression of astrocytic brain-derived neurotrophic factor in WT but not TDAG8 mice. Overexpressing TDAG8 in astrocytes surrounding the lesion in TDAG8 mice restored the beneficial effects of DCPC. Although the effects of DCPC on Days 14-28 were much weaker than those of DCPC on Days 3-28 in WT mice, these effects were further enhanced by overexpressing astrocytic TDAG8. Astrocytic TDAG8 is a key target of DCPC for TBI rehabilitation. Its overexpression is a strategy that broadens the therapeutic window and enhances the effects of DCPC.
T 细胞死亡相关基因 8(TDAG8)是一种感应生理或弱酸性的 G 蛋白偶联受体,可调节炎症反应。然而,其在创伤性脑损伤(TBI)中的作用尚不清楚。我们最近的研究表明,延迟一氧化碳后处理(DCPC)在 TBI 后具有神经修复作用。我们假设激活星形胶质细胞 TDAG8 是 DCPC 的关键机制。WT 和 TDAG8 小鼠在接受皮质撞击(CCI)后通过短暂吸入 10%CO 来接受每日 DCPC。HBAAV2/9-GFAP-m-TDAG8-3xflag-EGFP 用于在星形胶质细胞中过表达 TDAG8。通过束走测试、mNSS、免疫荧光和高尔基-考克斯染色来评估运动功能、神经胶质激活和树突可塑性。DCPC 显著改善了运动功能;增加了总树突长度、神经元复杂性和棘突密度;抑制了星形胶质细胞和小胶质细胞的过度激活;并促进了 WT 但不是 TDAG8 小鼠星形胶质细胞中脑源性神经营养因子的表达。在 TDAG8 小鼠损伤周围星形胶质细胞中过表达 TDAG8 恢复了 DCPC 的有益作用。尽管 DCPC 在 WT 小鼠中的第 14-28 天的效果比第 3-28 天的效果弱得多,但通过过表达星形胶质细胞 TDAG8 进一步增强了这些效果。星形胶质细胞 TDAG8 是 DCPC 治疗 TBI 康复的关键靶标。其过表达是一种拓宽治疗窗口和增强 DCPC 效果的策略。